151 related articles for article (PubMed ID: 25048253)
1. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis.
Palanisamy AP; Schiltz CE; Pilch NA; Hunt KJ; Nadig SN; Dowden JE; McGillicuddy JW; Baliga PK; Chavin KD; Taber DJ
Blood Press; 2015 Feb; 24(1):14-22. PubMed ID: 25048253
[TBL] [Abstract][Full Text] [Related]
2. Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?
Ozieh MN; Taber DJ; Egede LE
Medicine (Baltimore); 2015 Dec; 94(49):e2283. PubMed ID: 26656377
[TBL] [Abstract][Full Text] [Related]
3. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients.
Taber DJ; Gebregziabher M; Srinivas T; Egede LE; Baliga PK
Ann Transplant; 2018 Feb; 23():119-128. PubMed ID: 29449524
[TBL] [Abstract][Full Text] [Related]
4. African American polycystic kidney patients receive higher risk kidneys, but do not face increased risk for graft failure or post-transplant mortality.
Williams N; Korneffel K; Koizumi N; Ortiz J
Am J Surg; 2021 May; 221(5):1093-1103. PubMed ID: 33028497
[TBL] [Abstract][Full Text] [Related]
5. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.
Taber DJ; Gebregziabher M; Hunt KJ; Srinivas T; Chavin KD; Baliga PK; Egede LE
Kidney Int; 2016 Oct; 90(4):878-87. PubMed ID: 27555121
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.
Taber DJ; Su Z; Fleming JN; McGillicuddy JW; Posadas-Salas MA; Treiber FA; Dubay D; Srinivas TR; Mauldin PD; Moran WP; Baliga PK
Transplantation; 2017 Dec; 101(12):2931-2938. PubMed ID: 28658199
[TBL] [Abstract][Full Text] [Related]
7. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients.
Taber DJ; Douglass K; Srinivas T; McGillicuddy JW; Bratton CF; Chavin KD; Baliga PK; Egede LE
Am J Nephrol; 2014; 40(1):19-28. PubMed ID: 24969370
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients.
Taber DJ; Hamedi M; Rodrigue JR; Gebregziabher MG; Srinivas TR; Baliga PK; Egede LE
Transplantation; 2016 Jul; 100(7):1550-7. PubMed ID: 26425875
[TBL] [Abstract][Full Text] [Related]
9. A Contemporary Analysis of Outcomes and Modifiable Risk Factors of Ethnic Disparities in Kidney Transplantation.
Wilkins LJ; Nyame YA; Gan V; Lin S; Greene DJ; Flechner SM; Modlin CS
J Natl Med Assoc; 2019 Apr; 111(2):202-209. PubMed ID: 30409716
[TBL] [Abstract][Full Text] [Related]
10. The impact of diabetes on ethnic disparities seen in kidney transplantation.
Taber DJ; Meadows HB; Pilch NA; Chavin KD; Baliga PK; Egede LE
Ethn Dis; 2013; 23(2):238-44. PubMed ID: 23530307
[TBL] [Abstract][Full Text] [Related]
11. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age.
Schold JD; Srinivas TR; Braun WE; Shoskes DA; Nurko S; Poggio ED
Clin Transplant; 2011; 25(5):721-30. PubMed ID: 20964717
[TBL] [Abstract][Full Text] [Related]
12. Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal.
Liu A; Woodside KJ; Augustine JJ; Sarabu N
Clin Transplant; 2018 Sep; 32(9):e13381. PubMed ID: 30098053
[TBL] [Abstract][Full Text] [Related]
13. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients.
Taber DJ; Gebregziabher MG; Srinivas TR; Chavin KD; Baliga PK; Egede LE
Pharmacotherapy; 2015 Jun; 35(6):569-77. PubMed ID: 26011276
[TBL] [Abstract][Full Text] [Related]
14. Short-term kidney transplant outcomes among African American recipients do not predict long-term outcomes: donor pair analysis.
Keith D; Patrie JT
Clin Transplant; 2011; 25(1):69-76. PubMed ID: 20201952
[TBL] [Abstract][Full Text] [Related]
15. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study.
Taber DJ; Su Z; Fleming JN; Pilch NA; Morinelli T; Mauldin P; Dubay D
Transpl Int; 2019 Jan; 32(1):84-94. PubMed ID: 30176087
[TBL] [Abstract][Full Text] [Related]
16. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.
Taber DJ; Hunt KJ; Fominaya CE; Payne EH; Gebregziabher M; Srinivas TR; Baliga PK; Egede LE
Hypertension; 2016 Sep; 68(3):715-25. PubMed ID: 27402921
[TBL] [Abstract][Full Text] [Related]
17. Racial Disparity in Renal Transplantation: Alemtuzumab the Great Equalizer?
Smith AA; John MM; Dortonne IS; Paramesh AS; Killackey M; Jaffe BM; Buell JF
Ann Surg; 2015 Oct; 262(4):669-74. PubMed ID: 26366547
[TBL] [Abstract][Full Text] [Related]
18. The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression.
Gralla J; Le CN; Cooper JE; Wiseman AC
Clin Transplant; 2014 Mar; 28(3):292-8. PubMed ID: 24476453
[TBL] [Abstract][Full Text] [Related]
19. Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor.
Zakrzewska A; Tylicki L; Debska-Slizien A
Transplant Proc; 2018; 50(6):1838-1841. PubMed ID: 30056911
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
